Pathway Category Top Level |
Pathway Category Second Level |
Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
09160 Human Diseases |
09161 Cancers |
hsa05215 |
Prostate cancer |
1.687E-06 |
1.772E-04 |
EP300, MAPK1, TP53 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04919 |
Thyroid hormone signaling pathway |
3.953E-06 |
2.075E-04 |
EP300, MAPK1, TP53 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05161 |
Hepatitis B |
7.500E-06 |
2.625E-04 |
EP300, MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05203 |
Viral carcinogenesis |
2.075E-05 |
5.446E-04 |
EP300, MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04010 |
MAPK signaling pathway |
3.982E-05 |
6.969E-04 |
MAPK1, MAPT, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05206 |
MicroRNAs in cancer |
6.272E-05 |
8.233E-04 |
EP300, MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05216 |
Thyroid cancer |
3.034E-05 |
6.372E-04 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05200 |
Pathways in cancer |
1.485E-04 |
1.015E-03 |
EP300, MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05223 |
Non-small cell lung cancer |
1.147E-04 |
1.015E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05219 |
Bladder cancer |
6.118E-05 |
8.233E-04 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05213 |
Endometrial cancer |
9.879E-05 |
1.015E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05214 |
Glioma |
1.547E-04 |
1.015E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05210 |
Colorectal cancer |
1.407E-04 |
1.015E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05212 |
Pancreatic cancer |
1.595E-04 |
1.015E-03 |
MAPK1, TP53 |
09150 Organismal Systems |
09156 Nervous system |
hsa04720 |
Long-term potentiation |
1.595E-04 |
1.015E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09161 Cancers |
hsa05211 |
Renal cell carcinoma |
1.595E-04 |
1.015E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09161 Cancers |
hsa05218 |
Melanoma |
1.847E-04 |
1.053E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05230 |
Central carbon metabolism in cancer |
1.644E-04 |
1.015E-03 |
MAPK1, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05220 |
Chronic myeloid leukemia |
1.953E-04 |
1.053E-03 |
MAPK1, TP53 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04916 |
Melanogenesis |
3.664E-04 |
1.749E-03 |
EP300, MAPK1 |
09140 Cellular Processes |
09144 Cellular community - eukaryotes |
hsa04520 |
Adherens junction |
2.006E-04 |
1.053E-03 |
EP300, MAPK1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04350 |
TGF-beta signaling pathway |
2.586E-04 |
1.293E-03 |
EP300, MAPK1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04066 |
HIF-1 signaling pathway |
3.887E-04 |
1.775E-03 |
EP300, MAPK1 |
09150 Organismal Systems |
09156 Nervous system |
hsa04726 |
Serotonergic synapse |
4.594E-04 |
2.010E-03 |
ALOX15, MAPK1 |
09150 Organismal Systems |
09156 Nervous system |
hsa04722 |
Neurotrophin signaling pathway |
5.272E-04 |
2.129E-03 |
MAPK1, TP53 |
09140 Cellular Processes |
09143 Cell growth and death |
hsa04210 |
Apoptosis |
7.165E-04 |
2.496E-03 |
MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04071 |
Sphingolipid signaling pathway |
5.272E-04 |
2.129E-03 |
MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04068 |
FoxO signaling pathway |
6.470E-04 |
2.342E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05160 |
Hepatitis C |
6.470E-04 |
2.342E-03 |
MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04310 |
Wnt signaling pathway |
7.370E-04 |
2.496E-03 |
EP300, TP53 |
09140 Cellular Processes |
09143 Cell growth and death |
hsa04110 |
Cell cycle |
5.627E-04 |
2.188E-03 |
EP300, TP53 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05164 |
Influenza A |
1.116E-03 |
3.550E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09163 Neurodegenerative diseases |
hsa05010 |
Alzheimer's disease |
1.029E-03 |
3.377E-03 |
MAPK1, MAPT |
09160 Human Diseases |
09163 Neurodegenerative diseases |
hsa05016 |
Huntington's disease |
1.355E-03 |
3.951E-03 |
EP300, TP53 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05152 |
Tuberculosis |
1.154E-03 |
3.564E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05169 |
Epstein-Barr virus infection |
1.482E-03 |
4.031E-03 |
EP300, TP53 |
09160 Human Diseases |
09161 Cancers |
hsa05205 |
Proteoglycans in cancer |
1.497E-03 |
4.031E-03 |
MAPK1, TP53 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04024 |
cAMP signaling pathway |
1.439E-03 |
4.031E-03 |
EP300, MAPK1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05168 |
Herpes simplex infection |
1.246E-03 |
3.737E-03 |
EP300, TP53 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05166 |
HTLV-I infection |
2.403E-03 |
6.308E-03 |
EP300, TP53 |